Embryonic origin and self-renewal of B-1a cells
B-1a 细胞的胚胎起源和自我更新
基本信息
- 批准号:9294927
- 负责人:
- 金额:$ 37.67万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-06-15 至 2021-05-31
- 项目状态:已结题
- 来源:
- 关键词:AdultAntibodiesAtherosclerosisB-LymphocytesBacteriaBacterial InfectionsBiological AssayBone MarrowCell CountCell LineageCell MaintenanceCell physiologyCellsClinicalDataDevelopmentEmbryoEncapsulatedEndothelial CellsFatty acid glycerol estersFetal LiverFetusFrequenciesGoalsGreater sac of peritoneumHematopoietic Stem Cell TransplantationHematopoietic stem cellsHomeostasisHost DefenseHumanHuman DevelopmentImmuneImmunoglobulin MImpairmentInnate Immune SystemInvestigationKidneyKnowledgeLifeLymphoidMaintenanceMesenteryMethodsMolecularMusNeonatalOmentumOrganOutcomePRC1 ProteinPathway interactionsPatientsPeritonealPlayPolycombProcessProteinsReportingResearchRoleSepsisSiteSourceStem cell transplantStem cellsSystemic Lupus ErythematosusT-LymphocyteTamoxifenTestingTimeTranslatingTransplantationVirus DiseasesYolk Sacbasecell typeexperimental studyfetalgene repressiongraft vs host diseasehigh riskhuman subjectinnovationmanmembermicrobialmouse modelperipheral bloodpostnatalpreventprogenitorreconstitutionself-renewalstemtool
项目摘要
PROJECT SUMMARY/ABSTRACT
B-1 cells are murine innate immune B cells that preferentially localize in the peritoneal cavity, secrete
natural antibodies in a T cell independent manner, and play important roles in the first line of defense against
bacterial or viral infections, sepsis, and atherosclerosis. Despite the importance of B-1 cells in host defense
and homeostasis, their developmental origin is not clear. CD5+B-1a cells residing in the peritoneal cavity can
be reconstituted by transplantation of fetal liver (FL) progenitors, but not by adult bone marrow (BM)
hematopoietic stem cells (HSCs). Thus B-1a cells are considered to be of fetal origin and the mechanisms that
maintain B-1a cells in adult life without being replenished by adult HSCs have yet to be elucidated. The overall
goal of the project is to determine the contribution of HSC-independent embryonic B-1 progenitor cells into the
adult peritoneal B-1a cells and define the mechanisms that maintain B-1a cells throughout adult life.
We have reported the presence of B-1 progenitor cells originated from hemogenic endothelial cells
(HECs) in the yolk sac (YS) in an HSC-deficient mouse model. Our recent preliminary data demonstrated that
fetal liver HSCs poorly reconstituted B-1a cells upon transplantation. Thus, we hypothesize that peritoneal B-
1a cells are derived from HECs and are totally independent of HSCs contributions at any stage of development
or adult life. In Aim 1, we will utilize a lineage tracing mouse model where one can mark HECs and their
progeny at a specific embryonic time point before HSC emergence by tamoxifen induction and we will
supplement this approach with HSC transplantation assays from fetus to neonatal and adult stages to prove
there is no contribution of HSCs into the B-1a cell pool. In Aim2, we will interrogate the molecular mechanisms
that maintain the self-replenishing ability of embryonic derived B-1a cells throughout life. Bmi1 is a polycomb
group protein that is critical for self-renewal of HSCs. We now report that the self-replenishing capacity of
Bmi1-/- and CD19Cre:Bmi1flox/flox B-1a cells is impaired, raising the hypothesis that Bmi1 plays an important role
in B-1a cell self-renewal. Since Bmi1-/- mice displayed a significantly more severe reduction in B-1a cell
number compared to CD19Cre:Bmi1flox/flox mice, we hypothesize that the B-1a cell microenvironment may be
altered in Bmi1-/- mice. We will examine a niche for B-1 cells, the recently reported fat-associated lymphoid
clusters (FALCs) in the omentum and mesentery, in Bmi1-/- mice. We will also pursue a downstream target of
Bmi1 as playing a role in B-1a self-renewal. These experiments consider cell intrinsic and extrinsic roles of
Bmi1 to define its critical role in B-1a cell maintenance and self-renewal. Our results will establish a new
paradigm for understanding B-1 cell development and maintenance in mice and will provide new tools to
translate to human investigation of B-1 like cells.
1
项目总结/摘要
B-1细胞是鼠先天免疫B细胞,其优先定位于腹膜腔中,分泌
天然抗体以不依赖于T细胞的方式存在,并在对抗T细胞的第一道防线中发挥重要作用。
细菌或病毒感染、败血症和动脉粥样硬化。尽管B-1细胞在宿主防御中的重要性
和体内平衡,它们的发育起源尚不清楚。驻留在腹膜腔中的CD 5 +B-1a细胞可以
通过移植胎肝(FL)祖细胞而不是通过成人骨髓(BM)重建
造血干细胞(HSC)。因此,B-1a细胞被认为是胎儿来源的,
维持B-1a细胞在成年期而不被成年HSC补充的方法还有待阐明。整体
该项目的目标是确定HSC非依赖性胚胎B-1祖细胞对造血干细胞的贡献。
成年腹膜B-1a细胞,并定义了在整个成年生活中维持B-1a细胞的机制。
我们已经报道了来源于造血内皮细胞的B-1祖细胞的存在
在HSC缺陷型小鼠模型中,在卵黄囊(YS)中的内皮细胞(HEC)。我们最近的初步数据表明,
胎肝HSC在移植后重建B-1a细胞较差。因此,我们假设腹膜B-
1a细胞来源于HEC,在任何发育阶段都完全不依赖HSC的贡献
或成人生活。在目标1中,我们将利用谱系追踪小鼠模型,其中可以标记HEC及其
在HSC出现之前的特定胚胎时间点通过他莫昔芬诱导子代,我们将
用从胎儿到新生儿和成人阶段的HSC移植试验补充该方法,以证明
HSC没有贡献到B-1a细胞库中。在Aim 2中,我们将询问
其维持胚胎来源的B-1a细胞在整个生命中的自我补充能力。Bmi 1是一种多梳型
这是一组对HSC自我更新至关重要的蛋白质。我们现在报告,
Bmi 1-/-和CD 19 Cre:Bmi 1 flox/flox B-1a细胞受损,提出了Bmi 1在其中发挥重要作用的假设
在B-1a细胞自我更新中。由于Bmi 1-/-小鼠在B-1a细胞中显示出显著更严重的减少,
与CD 19 Cre:Bmi 1 flox/flox小鼠相比,我们假设B-1a细胞微环境可能是
在Bmi 1-/-小鼠中改变。我们将研究B-1细胞的小生境,这是最近报道的脂肪相关淋巴细胞。
在Bmi 1-/-小鼠中,网膜和肠系膜中的细胞簇(CMCs)。我们还将追求下游目标,
Bmi 1在B-1a自我更新中起作用。这些实验考虑了细胞的内在和外在作用,
Bmi 1,以确定其在B-1a细胞维持和自我更新中的关键作用。我们的研究结果将建立一个新的
为理解小鼠B-1细胞的发育和维持提供了新的工具,
转化为人类研究B-1样细胞。
1
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Momoko Yoshimoto其他文献
Momoko Yoshimoto的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Momoko Yoshimoto', 18)}}的其他基金
Different roles of fetal- and adult-derived IgA secreting cells against GI infection
胎儿和成人 IgA 分泌细胞对抗胃肠道感染的不同作用
- 批准号:
10722743 - 财政年份:2023
- 资助金额:
$ 37.67万 - 项目类别:
Embryonic origin and self-renewal of B-1a cells
B-1a 细胞的胚胎起源和自我更新
- 批准号:
9174956 - 财政年份:2016
- 资助金额:
$ 37.67万 - 项目类别:
Embryonic origin and self-renewal of B-1a cells
B-1a 细胞的胚胎起源和自我更新
- 批准号:
9379130 - 财政年份:2016
- 资助金额:
$ 37.67万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 37.67万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 37.67万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 37.67万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 37.67万 - 项目类别:
Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 37.67万 - 项目类别:
Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 37.67万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 37.67万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
- 批准号:
10639161 - 财政年份:2023
- 资助金额:
$ 37.67万 - 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
- 批准号:
10752441 - 财政年份:2023
- 资助金额:
$ 37.67万 - 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
- 批准号:
10867639 - 财政年份:2023
- 资助金额:
$ 37.67万 - 项目类别: